BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
50 results:

  • 1. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
    Tefferi A; Vannucchi AM; Barbui T
    Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
    Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
    Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
    [No Abstract]    [Full Text] [Related]  

  • 3. The Prognostic Impact of Preoperative Osteopenia in Patients With Colorectal cancer.
    Kato H; Seishima R; Mizuno S; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
    Dis Colon Rectum; 2023 Dec; 66(12):e1225-e1233. PubMed ID: 37699124
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation in patients with calr-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.
    Hernández-Boluda JC; Eikema DJ; Koster L; Kröger N; Robin M; de Witte M; Finke J; Finazzi MC; Broers A; Raida L; Schaap N; Chiusolo P; Verbeek M; Hazenberg CLE; Halaburda K; Kulagin A; Labussière-Wallet H; Gedde-Dahl T; Rabitsch W; Raj K; Drozd-Sokolowska J; Battipaglia G; Polverelli N; Czerw T; Yakoub-Agha I; McLornan DP
    Bone Marrow Transplant; 2023 Dec; 58(12):1357-1367. PubMed ID: 37679647
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnosis- and prognosis-Related Gene Alterations in
    Morishita S; Komatsu N
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
    [No Abstract]    [Full Text] [Related]  

  • 6. High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.
    Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Mroczkowska-Bękarciak A; Sobas M; Lewandowski K
    J Appl Genet; 2023 Sep; 64(3):479-491. PubMed ID: 37507589
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer.
    Fan J; Zhang L; Lv T; Liu Y; Sun H; Miao K; Jiang C; Li L; Pan X
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9229-9241. PubMed ID: 37199837
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of bone Metastasis in Renal Cell Carcinoma Patients.
    Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
    Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk, Prognostic Factors and Nomograms for bone Metastasis in Young Females with Breast cancer: A Large Cohort Retrospective Study.
    Liu Z; Xue J; Liu K; Fan Z; Liu D; Wang D
    Altern Ther Health Med; 2023 Jan; 29(1):182-190. PubMed ID: 36074969
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast cancer.
    Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
    Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
    Tashakori M; Khoury JD; Routbort MJ; Patel KP; Wang SA; Ok CY; El-Hussein S; Kanagal-Shamanna R; Luthra R; Hu S; Lin P; Pemmaraju N; Bose P; Verstovsek S; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Mod Pathol; 2022 Nov; 35(11):1677-1683. PubMed ID: 35690645
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Establishment and Validation of Immune Risk Score for Predicting Survival of Patients with Acute Myeloid Leukemia].
    Hu F; Wang Y; Zhang Y; Zeng Y; Wang SQ; Pan XY; Yang TH; Liu QF; Liang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):327-333. PubMed ID: 35395958
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. How I Diagnose Primary Myelofibrosis.
    Prakash S; Orazi A
    Am J Clin Pathol; 2022 Apr; 157(4):518-530. PubMed ID: 35238345
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
    Pasca S; Chifotides HT; Verstovsek S; Bose P
    Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape.
    Tefferi A; Gangat N; Pardanani A; Crispino JD
    Cancer Res; 2022 Mar; 82(5):749-763. PubMed ID: 34911786
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan].
    Morishita S
    Rinsho Ketsueki; 2021; 62(8):1060-1069. PubMed ID: 34497192
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review.
    Slot S; van de Donk NWCJ; Otten RHJ; Boden BJH; Zijlstra J; Raijmakers PGHM; Zweegman S
    Cancer Imaging; 2021 Apr; 21(1):36. PubMed ID: 33879266
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.
    Ortolan E; Appierto V; Silvestri M; Miceli R; Veneroni S; Folli S; Pruneri G; Vingiani A; Belfiore A; Cappelletti V; Vismara M; Dell'Angelo F; De Cecco L; Bianchi GV; de Braud FG; Daidone MG; Di Cosimo S
    ESMO Open; 2021 Apr; 6(2):100086. PubMed ID: 33743331
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The prognostic significance of lymphovascular tumor invasion in localized high-grade osteosarcoma: Outcomes of a single institution over 10 years.
    Gusho CA; Miller I; Clayton B; Colman MW; Gitelis S; Blank AT
    J Surg Oncol; 2021 Jun; 123(7):1624-1632. PubMed ID: 33621357
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.